Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases.

Zaiss DM, Bekker CP, Gröne A, Lie BA, Sijts AJ.

J Immunol. 2011 Sep 1;187(5):2302-9. doi: 10.4049/jimmunol.1101003. Epub 2011 Jul 29.

PMID:
21804012
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Novel automated blood separations validate whole cell biomarkers.

Burger DE, Wang L, Ban L, Okubo Y, Kühtreiber WM, Leichliter AK, Faustman DL.

PLoS One. 2011;6(7):e22430. doi: 10.1371/journal.pone.0022430. Epub 2011 Jul 22.

PMID:
21799852
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.

Zhang GL, Zou YF, Feng XL, Shi HJ, Du XF, Shao MH, Gu Y, Zhou Q.

Inflamm Res. 2011 Jan;60(1):11-8. doi: 10.1007/s00011-010-0216-2. Epub 2010 May 21.

PMID:
20495844
[PubMed - indexed for MEDLINE]
4.

The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.

Vereecke L, Beyaert R, van Loo G.

Trends Immunol. 2009 Aug;30(8):383-91. doi: 10.1016/j.it.2009.05.007. Epub 2009 Jul 28. Review.

PMID:
19643665
[PubMed - indexed for MEDLINE]
5.

Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk.

Achenbach P, Lampasona V, Landherr U, Koczwara K, Krause S, Grallert H, Winkler C, Pflüger M, Illig T, Bonifacio E, Ziegler AG.

Diabetologia. 2009 Sep;52(9):1881-8. doi: 10.1007/s00125-009-1438-0. Epub 2009 Jul 10.

PMID:
19590848
[PubMed - indexed for MEDLINE]
6.

Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.

Trynka G, Zhernakova A, Romanos J, Franke L, Hunt KA, Turner G, Bruinenberg M, Heap GA, Platteel M, Ryan AW, de Kovel C, Holmes GK, Howdle PD, Walters JR, Sanders DS, Mulder CJ, Mearin ML, Verbeek WH, Trimble V, Stevens FM, Kelleher D, Barisani D, Bardella MT, McManus R, van Heel DA, Wijmenga C.

Gut. 2009 Aug;58(8):1078-83. doi: 10.1136/gut.2008.169052. Epub 2009 Feb 24.

PMID:
19240061
[PubMed - indexed for MEDLINE]
7.

Autoimmune diseases induced by TNF-targeted therapies.

Ramos-Casals M, Brito-Zerón P, Soto MJ, Cuadrado MJ, Khamashta MA.

Best Pract Res Clin Rheumatol. 2008 Oct;22(5):847-61. doi: 10.1016/j.berh.2008.09.008. Review.

PMID:
19028367
[PubMed - indexed for MEDLINE]
8.

Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases.

Ko JM, Gottlieb AB, Kerbleski JF.

J Dermatolog Treat. 2009;20(2):100-8. doi: 10.1080/09546630802441234. Review.

PMID:
18923992
[PubMed - indexed for MEDLINE]
9.

Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism.

Ban L, Zhang J, Wang L, Kuhtreiber W, Burger D, Faustman DL.

Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13644-9. doi: 10.1073/pnas.0803429105. Epub 2008 Aug 28.

PMID:
18755894
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The IkappaBL gene polymorphism influences risk of acquiring systemic lupus erythematosus and Sjögren's syndrome.

Castiblanco J, Anaya JM.

Hum Immunol. 2008 Jan;69(1):45-51. doi: 10.1016/j.humimm.2007.11.008. Epub 2007 Dec 26.

PMID:
18295675
[PubMed - indexed for MEDLINE]
11.

Unstable diabetes in a patient receiving anti-TNF-alpha for rheumatoid arthritis.

Boulton JG, Bourne JT.

Rheumatology (Oxford). 2007 Jan;46(1):178-9. Epub 2006 Sep 23. No abstract available.

PMID:
16998233
[PubMed - indexed for MEDLINE]
Free Article
12.

Modulation of tumor necrosis factor by microbial pathogens.

Rahman MM, McFadden G.

PLoS Pathog. 2006 Feb;2(2):e4. Review.

PMID:
16518473
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.

Pinkse GG, Tysma OH, Bergen CA, Kester MG, Ossendorp F, van Veelen PA, Keymeulen B, Pipeleers D, Drijfhout JW, Roep BO.

Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18425-30. Epub 2005 Dec 9.

PMID:
16339897
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis.

Kodama S, Davis M, Faustman DL.

Cell Mol Life Sci. 2005 Aug;62(16):1850-62. Review.

PMID:
15968469
[PubMed - indexed for MEDLINE]
15.

Association of anti-tumor necrosis factor therapy with the development of multiple sclerosis.

Enayati PJ, Papadakis KA.

J Clin Gastroenterol. 2005 Apr;39(4):303-6.

PMID:
15758624
[PubMed - indexed for MEDLINE]
16.

The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression.

Till A, Rosenstiel P, Krippner-Heidenreich A, Mascheretti-Croucher S, Croucher PJ, Schäfer H, Scheurich P, Seegert D, Schreiber S.

J Biol Chem. 2005 Feb 18;280(7):5994-6004. Epub 2004 Nov 30.

PMID:
15572357
[PubMed - indexed for MEDLINE]
Free Article
17.

In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.

Qin HY, Chaturvedi P, Singh B.

Int Immunol. 2004 Dec;16(12):1723-32. Epub 2004 Oct 18.

PMID:
15492021
[PubMed - indexed for MEDLINE]
Free Article
18.

A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes.

Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S, Podolsky RH, Muir A, Wang J, Dong Z, Brusko T, Atkinson M, Pozzilli P, Zeidler A, Raffel LJ, Jacob CO, Park Y, Serrano-Rios M, Larrad MT, Zhang Z, Garchon HJ, Bach JF, Rotter JI, She JX, Wang CY.

Nat Genet. 2004 Aug;36(8):837-41. Epub 2004 Jul 11. Erratum in: Nat Genet. 2004 Sep;36(9):1024.

PMID:
15247916
[PubMed - indexed for MEDLINE]
19.

A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus.

Bohren KM, Nadkarni V, Song JH, Gabbay KH, Owerbach D.

J Biol Chem. 2004 Jun 25;279(26):27233-8. Epub 2004 Apr 29.

PMID:
15123604
[PubMed - indexed for MEDLINE]
Free Article
20.

Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease.

Thomas CW Jr, Weinshenker BG, Sandborn WJ.

Inflamm Bowel Dis. 2004 Jan;10(1):28-31.

PMID:
15058523
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk